Related Experiment Video
Updated: Feb 2, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.9K
Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study
Sara S McCoy1, Zubin Mukadam2, Keith C Meyer2
1Division of Rheumatology, Department of Internal Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA, ssmccoy@medicine.wisc.edu.
Therapeutics and Clinical Risk Management
|November 23, 2018
Summary
Interstitial pneumonia with autoimmune features (IPAF) patients may benefit from mycophenolate therapy, though further research is needed. This study observed a trend toward improved lung function in treated individuals.
Area of Science:
- Pulmonology
- Rheumatology
- Immunology
Background:
- Interstitial pneumonia with autoimmune features (IPAF) is a provisional diagnosis for interstitial lung disease (ILD) patients with autoimmune characteristics who don't meet criteria for specific autoimmune diseases.
- Understanding IPAF's clinical features and treatment responses is crucial for managing this complex condition.
Purpose of the Study:
- To describe the clinical characteristics of patients diagnosed with IPAF.
- To evaluate the therapeutic response to mycophenolate in IPAF patients.
Main Methods:
- Retrospective cohort study of adult patients meeting European Respiratory Society/American Thoracic Society IPAF criteria.
- Longitudinal analysis of sociodemographic, clinical, and pulmonary function test data, comparing mycophenolate-treated and untreated groups.
Main Results:
- 52 IPAF patients were identified; 28 received mycophenolate, 24 did not.
- No significant difference in FVC% or DLCO% change between groups (P=0.08, P=0.17).
- A trend towards improved FVC% and DLCO% slopes was observed after mycophenolate initiation in the treated group.
Conclusions:
- Mycophenolate therapy may offer potential benefits for patients with IPAF.
- Larger prospective clinical trials are necessary to definitively establish mycophenolate's efficacy in IPAF.
Related Concept Videos
01:30Pneumonia I: Introduction
895
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
895
01:29Pneumonia II: Pathophysiology
2.9K
The pathophysiology of pneumonia involves the following steps:
2.9K
01:29Autoimmune Disorders
1.8K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.8K
01:28Pneumonia IV: Management
816
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
816
00:59Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
01:30Pneumonia V: Nursing management and Prevention
3.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K